Target intelligence / Profile preview

Lipid rafts on antigen-presenting cells

Molecular classification
Membrane microdomain, Lipid-protein assembly
01

Overview

Cholesterol-rich cell membrane domains, commonly referred to as lipid rafts, are specialized microdomains within the plasma membrane of antigen-presenting cells (APCs) that are enriched in cholesterol, sphingolipids, and specific proteins (Varshney et al., 2016). These domains serve as organizing centers for signaling molecules, facilitating the assembly of the immunological synapse between APCs and T cells (Anderson et al., 2000). By concentrating major histocompatibility complex (MHC) molecules and co-stimulatory proteins, lipid rafts play a critical role in efficient antigen presentation and subsequent T-cell activation (Gidwani et al., 2003). In various diseases, including autoimmune disorders and chronic inflammation, the dysregulation of these domains can lead to aberrant immune responses. Pharmacological modulation of lipid rafts, often through cholesterol depletion or sequestration using agents like statins or methyl-beta-cyclodextrin, is explored as a strategy to dampen overactive immune signaling or prevent pathogen entry (Zidovetzki & Levitan, 2007).

Other names
Lipid raftsMembrane microdomainsDetergent-resistant membranes (DRMs)Cholesterol-rich microdomainsMembrane rafts
02

Mechanism of action

Disruption of membrane microdomain integrity through cholesterol depletion or sequestration, leading to the dissociation of signaling complexes and inhibition of antigen presentation.

03

Biological functions

Antigen presentationSignal transductionImmunological synapse formationT-cell activationEndocytosisCell-cell communication
04

Disease associations

Autoimmune diseaseInflammationInfection (viral and bacterial entry)CancerNeurodegenerative disease
05

Safety considerations

Non-specific membrane disruption in non-target cellsPotential for systemic lipid dysregulationImpairment of essential cellular signaling pathwaysCytotoxicity at high concentrations of sequestering agents
06

Interacting drugs

Atorvastatin

5 more in the full profile.

07

Biomarkers

Membrane cholesterol contentFlotillin-1 expressionGM1 ganglioside levels (Cholera Toxin B binding)MHC class II surface clusteringCaveolin-1 expression

Beyond the preview

Go deeper on Lipid rafts on antigen-presenting cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid rafts on antigen-presenting cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call